Filing Details
- Accession Number:
- 0001127602-23-006642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-23 09:54:27
- Reporting Period:
- 2023-02-21
- Accepted Time:
- 2023-02-23 09:54:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791393 | R Paul Kirchgraber | 531 South Spring Street Burlington NC 27215 | Ceo, Covance Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-21 | 3,000 | $182.51 | 17,069 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-21 | 8,000 | $250.58 | 9,069 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2023-02-21 | 3,000 | $0.00 | 3,000 | $182.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,300 | 2021-02-04 | 2030-02-03 | No | 4 | M | Direct |
Footnotes
- The price of $250.5844 per share represents a weighted average of sales prices ranging from $250.44 to $250.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- The option vested in three equal annual installments beginning on the date reflected in this column.
Billionaire Hedge Funds
